The dynamics of the CHO host cell protein profile during clarification and protein A capture in a platform antibody purification process
- 13 July 2012
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 110 (1) , 240-251
Abstract
Recombinant protein products such as monoclonal antibodies (mAbs) for use in the clinic must be clear of host cell impurities such as host cell protein (HCP), DNA/RNA, and high molecular weight immunogenic aggregates. Despite the need to remove and monitor HCPs, the nature, and fate of these during downstream processing (DSP) remains poorly characterized. We have applied a proteomic approach to investigate the dynamics and fate of HCPs in the supernatant of a mAb producing cell line during early DSP including centrifugation, depth filtration, and protein A capture chromatography. The primary clarification technique selected was shown to influence the HCP profile that entered subsequent downstream steps. MabSelect protein A chromatography removed the majority of contaminating proteins, however using 2D‐PAGE we could visualize not only the antibody species in the eluate (heavy and light chain) but also contaminant HCPs. These data showed that the choice of secondary clarification impacts upon the HCP profile post‐protein A chromatography as differences arose in both the presence and abundance of specific HCPs when depth filters were compared. A number of intracellularly located HCPs were identified in protein A elution fractions from a Null cell line culture supernatant including the chaperone Bip/GRP78, heat shock proteins, and the enzyme enolase. We demonstrate that the selection of early DSP steps influences the resulting HCP profile and that 2D‐PAGE can be used for monitoring and identification of HCPs post‐protein A chromatography. This approach could be used to screen cell lines or hosts to select those with reduced HCP profiles, or to identify HCPs that are problematic and difficult to remove so that cell‐engineering approaches can be applied to reduced, or eliminate, such HCPs. Biotechnol. Bioeng. 2013; 110: 240–251.Keywords
This publication has 30 references indexed in Scilit:
- Separation science is the key to successful biopharmaceuticalsJournal of Chromatography A, 2011
- Advances in the production and downstream processing of antibodiesNew Biotechnology, 2011
- Two‐dimensional difference fluorescence gel electrophoresis to verify the scale‐up of a non‐affinity‐based downstream process for isolation of a therapeutic recombinant antibodyElectrophoresis, 2010
- Profiling of host cell proteins by two‐dimensional difference gel electrophoresis (2D‐DIGE): Implications for downstream process developmentBiotechnology and Bioengineering, 2009
- Ultra Scale‐Down To Define and Improve the Relationship between Flocculation and Disc‐Stack CentrifugationBiotechnology Progress, 2008
- A method for three‐dimensional protein characterization and its application to a complex plant (corn) extractBiotechnology and Bioengineering, 2007
- On the statistical analysis of the GS-NS0 cell proteome: Imputation, clustering and variability testingBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2006
- Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verificationBiotechnology and Bioengineering, 2006
- Proteomic analysis of enriched microsomal fractions from GS‐NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivitiesProteomics, 2005
- Performance prediction of industrial centrifuges using scale-down modelsBioprocess and Biosystems Engineering, 2003